10-K Filing

22ND CENTURY GROUP, INC. CIK: 1347858 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001144204-12-021812`
Period End Date	20111231
Filing Date	20120416
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	xxii-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 35 Cash Flow Statement 73 Stockholders Equity 18 Comprehensive Income 2

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Authorized, preferred shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Authorized, preferred shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Cash	`Cash`	$252.25K	USD	Point-in-time
Cash	`Cash`	$158.00	USD	Point-in-time
Cash	`Cash`	$310.00	USD	Point-in-time
Authorized, common shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Authorized, common shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common shares, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common shares, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Grant receivable	`GrantsReceivableCurrent`	$223.54K	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$15.49K	USD	Point-in-time
Issued, preferred shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Issued, preferred shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Outstanding, preferred shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Outstanding, preferred shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Due from officers	`DueFromOfficersOrStockholdersCurrent`	$7.71K	USD	Point-in-time
Inventory	`InventoryNet`	$308.66K	USD	Point-in-time
Issued, common shares	`CommonStockSharesIssued`	27.21M	shares	Point-in-time
Issued, common shares	`CommonStockSharesIssued`	16.00M	shares	Point-in-time
Inventory	`InventoryNet`	$678.12K	USD	Point-in-time
Outstanding, common shares	`CommonStockSharesOutstanding`	27.21M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$211.72K	USD	Point-in-time
Outstanding, common shares	`CommonStockSharesOutstanding`	16.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.68K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$744.23K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$971.25K	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.39M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.47M	USD	Point-in-time
Office furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$7.86K	USD	Point-in-time
Deferred private placement costs	`DeferredCosts`	$587.13K	USD	Point-in-time
Deferred debt isuance costs, net	`DeferredFinanceCostsCurrentNet`	$22.41K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$1.53K	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$2.06M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.42M	USD	Point-in-time
Total assets	`Assets`	$2.80M	USD	Point-in-time
Total assets	`Assets`	$2.39M	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.90M	USD	Point-in-time
Accrued interest payable to shareholders	`InterestPayableRelatedPartiesCurrent`	$21.50K	USD	Point-in-time
Accrued interest payable to shareholders	`InterestPayableRelatedPartiesCurrent`	$190.98K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$227.72K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$545.58K	USD	Point-in-time
Deferred grant revenue	`DeferredRevenueCurrent`	$223.54K	USD	Point-in-time
Notes payable to shareholders, net of unamortized discount	`NotesPayableRelatedPartiesClassifiedCurrent`	$1.10M	USD	Point-in-time
Notes payable to shareholders, net of unamortized discount	`NotesPayableRelatedPartiesClassifiedCurrent`	$25.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$400.00K	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleNotesPayableCurrent`	$641.89K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$6.94K	USD	Point-in-time
Due to officers	`DueToOfficersOrStockholdersCurrent`	$3.20K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.82M	USD	Point-in-time
Long term notes payable to shareholders, net of unamortized discount	`DueToRelatedPartiesNoncurrent`	$140.00K	USD	Point-in-time
Long term notes payable to shareholders, net of unamortized discount	`DueToRelatedPartiesNoncurrent`	$65.56K	USD	Point-in-time
Long term portion of notes payables	`LongTermNotesPayable`	$37.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$550.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.89M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
0 preferred shares	`PreferredStockValue`	-	USD	Point-in-time
0 preferred shares	`PreferredStockValue`	-	USD	Point-in-time
27,209,646 common shares (16,000,000 at December 31, 2010)	`CommonStockValue`	$273.00	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$3.60M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$5.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.04M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.69M	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$5.98K	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$-134.00	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.80M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.80M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.39M	USD	Point-in-time

Income Statement 35 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$788.60K	USD	Annual
Revenue	`SalesRevenueNet`	$49.78K	USD	Annual
Other income - therapeutic grant	`RevenueFromGrants`	$223.54K	USD	Annual
Total revenue	`Revenues`	$1.01M	USD	Annual
Total revenue	`Revenues`	$49.78K	USD	Annual
Costs of goods sold	`CostOfGoodsSold`	$418.17K	USD	Annual
Costs of goods sold	`CostOfGoodsSold`	$27.96K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.10M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$363.78K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.79M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$590.83K	USD	Annual
Sales and marketing costs	`SellingAndMarketingExpense`	$286.03K	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$164.46K	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$179.95K	USD	Annual
Costs and Expenses, Total	`CostsAndExpenses`	$4.77M	USD	Annual
Costs and Expenses, Total	`CostsAndExpenses`	$1.15M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.76M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.10M	USD	Annual
Gain warrant liability - derivative	`DerivativeGainOnDerivative`	$2.51M	USD	Annual
Shareholders	`InterestExpenseRelatedParty`	$265.22K	USD	Annual
Shareholders	`InterestExpenseRelatedParty`	$45.93K	USD	Annual
Other	`InterestExpenseOther`	$61.18K	USD	Annual
Other	`InterestExpenseOther`	$58.07K	USD	Annual
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$-326.40K	USD	Annual
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$2.41M	USD	Annual
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-1.42M	USD	Annual
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-15.00	USD	Annual
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.12K	USD	Annual
Net loss attributed to common shareholders	`NetIncomeLoss`	$-1.42M	USD	Annual
Net loss attributed to common shareholders	`NetIncomeLoss`	$-1.35M	USD	Annual
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	Annual
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	26.39M	shares	Annual
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	12.44M	shares	Annual

Cash Flow Statement 73 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-1.42M	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$164.46K	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$179.95K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.09K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$35.92K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$126.62K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$34.09K	USD	Annual
Gain warrant liability - derivative	`DerivativeGainOnDerivative`	$2.51M	USD	Annual
Equity based employee compensation expense	`ShareBasedCompensation`	$144.34K	USD	Annual
Equity based employee compensation expense	`ShareBasedCompensation`	$376.44K	USD	Annual
Equity based payments for outside services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$2.19K	USD	Annual
Grant receivable	`IncreaseDecreaseInOtherReceivables`	$-223.54K	USD	Annual
Grant receivable	`IncreaseDecreaseInOtherReceivables`	$223.54K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$253.64K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$369.46K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$211.72K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-194.04K	USD	Annual
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$-1.53K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$190.52K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-222.66K	USD	Annual
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-162.77K	USD	Annual
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToOfficersAndStockholders`	$112.05K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$317.86K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$191.22K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$223.54K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-223.54K	USD	Annual
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.45M	USD	Annual
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-909.94K	USD	Annual
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$108.12K	USD	Annual
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$598.19K	USD	Annual
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	$9.11K	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-108.12K	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-607.30K	USD	Annual
Payment of deferred private placement costs	`PaymentsOfStockIssuanceCosts`	$60.98K	USD	Annual
Payment on demand loan	`RepaymentsOfShortTermDebt`	$71.81K	USD	Annual
Proceeds from issuance of notes and warrants to shareholders	`ProceedsFromIssuanceOfNotesAndWarrants`	$215.00K	USD	Annual
Proceeds from issuance of notes and warrants to shareholders	`ProceedsFromIssuanceOfNotesAndWarrants`	$723.27K	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.30M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$23.50K	USD	Annual
Payments on borrowings - notes payable to shareholders	`RepaymentsOfRelatedPartyDebt`	$393.28K	USD	Annual
Payments on borrowings - notes payable to shareholders	`RepaymentsOfRelatedPartyDebt`	$4.39K	USD	Annual
Payments on borrowings - notes payable	`RepaymentsOfNotesPayable`	$50.00K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$549.87K	USD	Annual
Net proceeds from January 25, 2011 private placement	`ProceedsFromIssuanceOrSaleOfEquity`	$3.29M	USD	Annual
Net payments to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-120.03K	USD	Annual
Net payments to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-22.43K	USD	Annual
Net (payments to) advances from officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$2.27K	USD	Annual
Net (payments to) advances from officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.91K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.31M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.02M	USD	Annual
Net increase in cash	`CashPeriodIncreaseDecrease`	$251.94K	USD	Annual
Net increase in cash	`CashPeriodIncreaseDecrease`	$152.00	USD	Annual
Cash - beginning of period	`Cash`	$252.25K	USD	Point-in-time
Cash - beginning of period	`Cash`	$158.00	USD	Point-in-time
Cash - beginning of period	`Cash`	$310.00	USD	Point-in-time
Cash - end of period	`Cash`	$252.25K	USD	Point-in-time
Cash - end of period	`Cash`	$158.00	USD	Point-in-time
Cash - end of period	`Cash`	$310.00	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$16.89K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$196.54K	USD	Annual
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	$500.00K	USD	Annual
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	$526.13K	USD	Annual
Accounts payable converted to promisory notes	`ConversionOfAccountsPayableToNotePayable`	$587.00K	USD	Annual
Supplemental Accounts Payable, Total	`SupplementalAccountsPayable`	$1.61M	USD	Annual
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	$587.13K	USD	Annual
Original issue discount on convertible debt	`DebtDiscount`	$251.25K	USD	Annual
Beneficial conversion value upon issuance of convertible debt recoded as debt discount and an increase in capital in excess of par value	`BeneficialConversionFeatureOfModifiedSubordinatedDebtAllocatedToCommonStock`	$1.06M	USD	Annual
Conversion of shareholder note and accrued interest to common shares and warrants	`ConversionOfConvertibleNotesToCommonStock`	$614.07K	USD	Annual
Conversion of shareholder note and accrued interest to common shares and warrants	`ConversionOfConvertibleNotesToCommonStock`	$31.31K	USD	Annual
Issuance of warrants as derivative liability instruments and reduction of capital in excess of par value	`IssuanceOfDerivativeLiabilityInstrumentsAndReductionOfAdditionalPaidInCapital`	$3.06M	USD	Annual
Patent and trademark additions included in accounts payable	`PatentAndTrademarkAdditionsIncludedInAccountsPayable`	$39.80K	USD	Annual
Deferred private placement cost additions included in accounts payable	`DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable`	$526.16K	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Warrants issued	`IssuanceOfWarrants`	$405.00K	USD	Annual
Distribution of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$43.11K	USD	Annual
Distribution of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$-1.55M	USD	Annual
Common Stock issued	`StockIssuedDuringPeriodValueNewIssues`	$549.87K	USD	Annual
Common Stock issued	`StockIssuedDuringPeriodValueNewIssues`	$2.34M	USD	Annual
Common Stock issued in exchange for services	`StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaims`	$2.19K	USD	Annual
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$376.44K	USD	Annual
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$33.00K	USD	Annual
Conversion of shareholder note and accrrued interest to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$31.31K	USD	Annual
Beneficial conversion feature of convertible debt	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$1.06M	USD	Annual
Net income (loss)	`ProfitLoss`	$-1.35M	USD	Annual
Net income (loss)	`ProfitLoss`	$-1.42M	USD	Annual
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.80M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time

Comprehensive Income 2 line items

Line Item	Tag	Value	Unit	Period
Distribution of warrants for common stock, warrants	`NumberOfCommonStockWarrantsDistributedToShareholders`	5.00M	shares	Annual
Distribution of warrants for common stock, exercise price	`InvestmentWarrantsExercisePrice`	$3.00	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.